Free Trial
CVE:DMT

Small Pharma (DMT) Stock Price, News & Analysis

Small Pharma logo
C$0.15 -0.01 (-6.25%)
As of 10/20/2023

About Small Pharma Stock (CVE:DMT)

Key Stats

Today's Range
C$0.15
C$0.16
50-Day Range
C$0.15
C$0.15
52-Week Range
C$0.06
C$0.22
Volume
1.89 million shs
Average Volume
296,159 shs
Market Capitalization
C$50.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DMT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Small Pharma and its competitors with MarketBeat's FREE daily newsletter.

DMT Stock News Headlines

Milestone Pharmaceuticals Prepares for CARDAMYST Approval
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
LTR Pharma’s SPONTAN Nasal Spray Poised for Global Impact
See More Headlines

DMT Stock Analysis - Frequently Asked Questions

Small Pharma's stock was trading at C$0.15 on January 1st, 2025. Since then, DMT stock has increased by 0.0% and is now trading at C$0.15.

Shares of DMT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Small Pharma investors own include Bombardier, Inc. Class B (BBD.B), Arrival (ARVL), Air Canada (AC), Beyond Meat (BYND), Biosig Technologies (BSGM), Aveanna Healthcare (AVAH) and Actinium Pharmaceuticals (ATNM).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:DMT
CIK
N/A
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$19.31 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-116.90%
Return on Assets
-66.00%

Debt

Debt-to-Equity Ratio
5.95
Current Ratio
2.63
Quick Ratio
6.28

Sales & Book Value

Annual Sales
-C$1.16 thousand
Price / Sales
-43,343.80
Cash Flow
C$0.13 per share
Price / Cash Flow
1.13
Book Value
C$0.03 per share
Price / Book
5.00

Miscellaneous

Outstanding Shares
335,770,000
Free Float
N/A
Market Cap
C$50.37 million
Optionable
Not Optionable
Beta
0.86
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (CVE:DMT) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners